Intelligence · Clinical pipeline
Infectious disease R&D Pipeline
Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Quick answer
Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Top sponsors
- United Therapeutics Europe 94 programs
- BRIGHT MINDS BIOSCIENCES 81 programs
- Chinese Academy of 77 programs
- Sinovac Research and 49 programs
- GSK Glaxo Smith 39 programs
- Takeda 33 programs
- First People's Hospital 31 programs
- Vertex Pharmaceuticals (Australia) 30 programs
- Vir Biotechnology 26 programs
- George Institute for 25 programs
- ENANTA PHARMACEUTICALS 22 programs
- Hospital Authority 22 programs
Pipeline programs
-
Regimen:TDF+3TC+EFV
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hiv
1 trial -
Regimen：BIC+FTC+TAF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HIV Infection
1 trial -
Renoir
The George Institute
Covid-19 infection
1 trial -
Rifaximin
United Therapeutics Europe Ltd
Clostridium Difficile Infection
1 trial -
SARS-CoV-2 Inactivated Vaccine
Sinovac Research and Development Co.,
COVID-19
2 trials -
Sertraline Hydrochloride
The First People's Hospital of Lianyungang
COVID-19 Vaccine Adverse Reaction
1 trial -
Short Cycle Antiretroviral Therapy
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
BRIGHT MINDS BIOSCIENCES INC.
HEPATITIS C (HCV)
1 trial -
Sofosbuvir/velpatasvir (Epclusa®)
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Malaria (Uncomplicated)
1 trial -
Sulforaphane
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
HIV Infections
1 trial -
TDF
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial -
TYRX™ Absorbable Antibacterial Envelope
Rhythm Pharmaceuticals Netherlands B.V.
CIED Related Infection
1 trial -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
11 trials -
Telbivudine treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Tenofovir Alafenamide 25 MG
The First People's Hospital of Lianyungang
Chronic Hepatitis C
1 trial -
Tenofovir Alafenamide Tablets
The First People's Hospital of Lianyungang
Chronic Hepatitis b
1 trial -
Tenofovir Alafenamide fumarate 25mg Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Tenofovir disoproxil fumarate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
The live attenuated varicella vaccine and the inactivated hepatitis A vaccine
Sinovac Research and Development Co.,
Varicella
1 trial -
The papillon study
Pierre Fabre Australia Pty Ltd
giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral
1 trial -
Tigecycline
Wyeth is now a wholly owned subsidiary of Pfizer
Skin Diseases, Bacterial
1 trial -
Trimebutine 100 MG
Hospital Authority, Hong Kong
Helicobacter Pylori Infection
1 trial -
Trivalent live attenuated seasonal influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial -
Ursodeoxycholic acid combined with total glucosides of paeony
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis
1 trial -
Vaccination to prevent hepatitis B virus infection
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B
1 trial -
Vancomycin
The First People's Hospital of Lianyungang
Blood Stream Infections
1 trial -
Vemlidy
Hospital Authority, Hong Kong
Chronic Hepatitis b
1 trial -
Video directly observed therapy with contingency management
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
2 trials -
Vonoprazan and Amoxicillin for the first 7 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Xuebijing Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
2 trials -
[68Ga]FAPI-46
Disc Medicine
post-acute sequelae of COVID-19
1 trial -
adefovir dipivoxil
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
albumin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
artemether lumefantrine
United Therapeutics Europe Ltd
Uncomplicated Malaria
1 trial -
artemether-lumefantrine (ALN)
United Therapeutics Europe Ltd
Uncomplicated Malaria
1 trial -
buprenorphine
Indivior Pty Ltd
Hepatitis C, Chronic
1 trial -
fluocinolone acetonide 190 micrograms
ANI PHARMACEUTICALS INC
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
1 trial -
lamivudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Compensated Chronic Hepatitis B
1 trial -
moxifloxacin
Hospital Authority, Hong Kong
Intra-abdominal Infection
1 trial -
oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
pegylated interferon alpha and plus ribavirin
Hospital Authority, Hong Kong
Chronic Hepatitis C
1 trial -
primaquine
Repatha
Malaria, Vivax
1 trial -
telbivudine (ROADMAP)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B, Chronic
1 trial -
treatment with CAZ-AVI
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Patients With Critically Ill Infections
1 trial -
0.9% NaCl physiological saline
Hospital Authority, Hong Kong
Acute Respiratory Tract Infections
1 trial -
ART initiation at time of HIV diagnosis
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial
Frequently asked questions
How many infectious disease pipeline programs are tracked?
1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.